Novel Orphan Nuclear Receptors-Coregulator Interactions Controlling Anti-Cancer Drug Metabolism

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|9|7|611-613

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.9, Iss.7, 2008-09, pp. : 611-613

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Orphan Nuclear Receptors as Targets for Drug Development

By Mukherjee Subhajit   Mani Sridhar  

Pharmaceutical Research, Vol. 27, Iss. 8, 2010-08 ,pp. : 1439-1468

Springer Publishing Company

Access to resources Recommend Favorite

Role of Orphan Nuclear Receptors in the Regulation of Drug-Metabolising Enzymes

By Wang H.   LeCluyse E.L.  

Clinical Pharmacokinetics, Vol. 42, Iss. 15, 2003-01 ,pp. : 1331-1357

Adis International

Access to resources Recommend Favorite

An update on ethnic differences in drug metabolism and toxicity from anti-cancer drugs

By Phan Viet Hong   Tan Cindy   Rittau Anneliese   Xu Hongmei   McLachlan Andrew J   Clarke Stephen J  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 11, 2011-11 ,pp. : 1395-1410

Informa Healthcare

Access to resources Recommend Favorite

Nuclear Receptors as Drug Targets: New Developments in Coregulators, Orphan Receptors and Major Therapeutic Areas

By Sladek Frances M  

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 5, 2003-10 ,pp. : 679-684

Informa Healthcare

Access to resources Recommend Favorite

An Insight into Drug Repositioning for the Development of Novel Anti-Cancer Drugs

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 19, 2016-08 ,pp. : 2156-2168

Bentham Science Publishers

Access to resources Recommend Favorite